文献速递慢阻肺

肺减容手术个体化风险:Glenfield BFG评分

Individualised risk in patients undergoing lung volume reduction surgery: the Glenfield BFG score.
PubMed 文献 · Eur Respir J · 2017-06-01

本研究基于237例肺减容手术(LVRS)患者开发个体化90天死亡风险评分,独立预测因素包括BMI<18.5 kg·m⁻²、FEV1<0.71 L和TLCO<20%。评分AUROC为0.80,优于单一因素,并在71例验证队列中AUROC达0.84。

要点

  • Glenfield BFG评分可个体化预测LVRS术后90天死亡风险。
  • BMI<18.5、FEV1<0.71 L、TLCO<20%与死亡独立相关。
  • 评分将患者分为三组风险,46%为低风险,各组肺功能改善相似。

核心结论

  • 可提供LVRS个体化预测风险评分,辅助临床决策。

研究设计与样本

  • cohort研究,237例LVRS手术患者用于评分开发,71例用于验证。

主要发现

  • 多因素分析中BMI<18.5 kg·m⁻²与死亡独立相关(OR 2.83,p=0.059)。
  • FEV1<0.71 L与死亡独立相关(OR 5.47,p=0.011)。
  • TLCO<20%与死亡独立相关(OR 5.56,p=0.031)。
  • 开发队列评分AUROC为0.80,优于单一组分(p<0.01)。
  • 验证队列71例中90天死亡AUROC为0.84。

关键数值与推荐

  • 评分将患者分为三个风险组,46%为低风险。
  • 所有风险组肺功能和健康状况改善相似。

临床怎么用

  • 可用于LVRS术前个体化风险评估,辅助医患决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lung volume reduction surgery (LVRS) has been shown to be beneficial in patients with chronic obstructive pulmonary disease, but there is low uptake, partly due to perceived concerns of high operative mortality. We aimed to develop an individualised risk score following LVRS.This was a cohort study of patients undergoing LVRS. Factors independently predicting 90-day mortality and a risk prediction score were identified. Reliability of the score was tested using area under the receiver operating characteristic curve (AUROC).237 LVRS procedures were performed. The multivariate analysis factors associated independently with death were: body mass index (BMI)<18.5 kg·m-2 (OR 2.83, p=0.059), forced expiratory volume in 1 s (FEV1)<0.71 L (OR 5.47, p=0.011) and transfer factor of the lung for carbon monoxide (TLCO) <20% (OR 5.56, p=0.031). A risk score was calculated and total score assigned. AUROC for the risk score was 0.80 and a better predictor than individual components (p<0.01). The score was stratified into three risk groups. Of the total patients, 46% were classified as low risk. Similar improvements in lung function and health status were seen in all groups. The score was introduced and tested in a further 71 patients. AUROC for 90-day mortality in this cohort was 0.84.It is possible to provide an individualised predictive risk score for LVRS, which may aid decision making for both clinicians and patients.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Greening NJ, Vaughan P, Oey I, et al. Individualised risk in patients undergoing lung volume reduction surgery: the Glenfield BFG score. Eur Respir J. 2017. PMID: 28572121. doi:10.1183/13993003.01766-2016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。